SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

SHG Singular Health Group Ltd

Healthcare · Health Information Services · website
$0.18
52wk 0.17 – 0.34
Overall
51.7
Value
54.5
Growth
100.0
Health
69.2
Quality
0.0
Momentum
12.0
Dividend
—
Price
About Singular Health Group Ltd

Singular Health Group Ltd, operates as a healthcare technology company in Australia. The company Volumetric Rendering Platform, a proprietary technology that enhances the visualization of patient anatomy and health issues by converting 2D images from CT, MRI, and PET scans into 3D models. It also provides Medical File Transfer Protocol, a technology that streamlines the access, sharing, and storage of medical images, such as CT, MRI, and PET scans across electronic devices and healthcare providers. In addition, the company offers AI in the Cloud that enhances medical imaging by integrating AI models. Further, it provides 3DICOM MD for healthcare professionals; 3DICOM EDU and XR for academics and researchers; and 3DICOM Patient for patients. Additionally, the company is involved in development and commercialization of the 3DICOM platform; enterprise healthcare imaging/interoperability solutions; education applications; and associated regulatory and product-development activities. Singular Health Group Ltd was incorporated in 2020 and is based in Leederville, Australia.

Price analytics

Returns

1 day 0.0%
1 week 2.8%
1 month -2.6%
3 months -11.9%
6 months -24.5%
1 year -32.7%
3 years 386.8%

Risk

Volatility (1y ann.) 79.8%
Beta vs ASX 200 0.76
Sharpe (1y) -0.16
VaR 95% (1-day) -7.9%
Max drawdown (1y) -41.7%
Off 1-year high -38.3%

Technicals

RSI(14) 50
vs 50DMA -0.8%
vs 200DMA -14.4%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 54.5
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
33
Price / Sales
0
Growth 100.0
Revenue growth (1y)
100
Revenue CAGR (3y)
100
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 69.2
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 12.0
6-month return vs ASX 200
0
Price vs 200-day average
2
Price vs 50-day average
46
Position in 52-week range
9

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$60.33M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
-0.02
Dividend yield
—
Payout ratio
0.0%
Beta
-0.03
EV / EBITDA
-7.53
Price / Book
5.61
ROE
-53.7%
Operating margin
-248.9%
Net margin
0.0%
Total cash
$10.06M
Total debt
$109,963
Current ratio
18.19
Debt / Equity
0.01
Free cash flow
$-3.30M
Avg volume
218,363
Latest annual results (FY ending 30 Jun 2026)
  • Revenue$1.43M
  • Gross profit$1.43M
  • Operating income-$7.25M
  • Net income-$6.34M
  • Diluted EPS—
  • Free cash flow-$5.45M
  • Net debt-$2.25M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4